1. 15 May 2024

   Pre-seed

   €935K

   Cumulative €935K

2. 07 Aug 2025 · +1 yr 3 mo

   Seed

   €3.3M

   Cumulative €4.2M

Amounts in EUR, converted at the ECB rate on the event date. Funding totals exclude debt, grants and state aid; rounds whose instrument is not yet established are still counted. Every figure links to its source.

• Funding07 Aug 2025EUR 3.3M

  Cellbox Labs raised EUR 3.3M in seed.

  ▸Source: EU-Startups

  Read at EU-Startups

• Funding15 May 2024EUR 935K

  Cellbox Labs raised EUR 935K in a pre-seed round led by Buildit, with LatBAN-affiliated angels participating, to develop automated organ-on-chip technology.

  ▸Source: Labs of Latvia

  Read at Labs of Latvia

• Artūrs Ābols

  Co-founder and CSO

• Gatis Mozoļevskis

  Co-founder and CEO

• Roberts Rimša

  Co-founder and CTO

Raised €4.2M to date · FY2025 turnover €114K · 15 employees

• Turnover grew 248% FY2024→FY2025.
• Headcount 6 → 15 over FY2024→FY2025.
• ≈€10K turnover per employee (FY2025).

What does Cellbox Labs do?

Develops organ-on-chip technology - miniature human-organ replicas (gut, microbiome, lung, cancer, vasculature models) plus an easy-to-use instrument, reducing animal testing and enabling more effective drug development.

When was Cellbox Labs founded?

Cellbox Labs was founded in 2020.

Where is Cellbox Labs headquartered?

Cellbox Labs is headquartered in Riga, Latvia.

How much funding has Cellbox Labs raised?

Cellbox Labs has raised €4.2M (across 2 rounds · last 07 Aug 2025).

What was Cellbox Labs's latest funding round?

Cellbox Labs's most recent disclosed round was a seed round of €3.3M, announced 7 August 2025.

Who has invested in Cellbox Labs?

Investors in Cellbox Labs include Buildit VC.

What is Cellbox Labs's revenue?

Cellbox Labs reported €114K in turnover for FY2025, per official registry filings.